Compounds > alosetron

alosetron and td-5108

alosetron has been researched along with td-5108 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Lacy, BE1
Kamm, MA1
Lewis, JH1
Chen, M; Qin, D; Tang, TC; Yue, L; Zheng, H1

Reviews

3 review(s) available for alosetron and td-5108

ArticleYear
Pharmacological treatment of irritable bowel syndrome--from concept to sales.
    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 2002, Issue:587

    Topics: Antidepressive Agents; Benzofurans; Carbolines; Cisapride; Constipation; Drug Industry; Gastrointestinal Agents; Humans; Indoles; Irritable Bowel Syndrome; Serotonin 5-HT3 Receptor Antagonists; Serotonin 5-HT4 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists

2002
The risk of ischaemic colitis in irritable bowel syndrome patients treated with serotonergic therapies.
    Drug safety, 2011, Jul-01, Volume: 34, Issue:7

    Topics: Animals; Carbolines; Colitis, Ischemic; Female; Humans; Indoles; Irritable Bowel Syndrome; Male; Serotonin 5-HT3 Receptor Antagonists; Serotonin 5-HT4 Receptor Agonists

2011
Pharmacologic Treatments for Irritable Bowel Syndrome: an Umbrella Systematic Review.
    Journal of gastrointestinal and liver diseases : JGLD, 2020, Jun-03, Volume: 29, Issue:2

    Topics: Carbolines; Gastrointestinal Agents; Guanylyl Cyclase C Agonists; Humans; Irritable Bowel Syndrome; Parasympatholytics; Serotonin 5-HT3 Receptor Antagonists; Serotonin 5-HT4 Receptor Agonists; Treatment Outcome

2020

Other Studies

1 other study(ies) available for alosetron and td-5108

ArticleYear
Therapy for irritable bowel syndrome.
    The New England journal of medicine, 2004, Mar-18, Volume: 350, Issue:12

    Topics: Carbolines; Humans; Indoles; Irritable Bowel Syndrome; Polypharmacy; Serotonin 5-HT3 Receptor Antagonists; Serotonin 5-HT4 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists

2004